ResMed acquires Noctrix Health for $340 million
Following the completion of the acquisition on June 3, Noctrix’s flagship product, Nidra will become part of ResMed’s broader sleep medicine portfolio
Following the completion of the acquisition on June 3, Noctrix’s flagship product, Nidra will become part of ResMed’s broader sleep medicine portfolio
This facility plays an important role in Granules’ global manufacturing and supply network
New regulation mandates stricter prescription monitoring, sales record maintenance, and enhanced compliance across the pharmaceutical supply chain
The company witnesses strong growth across its India, Africa, and emerging markets businesses, while securing regulatory approval for the first AB-rated gVentolin in the U.S. market
Initiative by National Health Authority aimed at accelerating automated claims processing under Ayushman Bharat Pradhan Mantri Jan Arogya Yojana
More than 3,500 participants will join the nationwide AI-focused hackathon hosted as Indian Institute of Science
The move aims to accelerate the development, commercialization, and global rollout of advanced AI-powered mammography tools
AI challenge offers Rs 10 lakh top prize and potential ?50 lakh deployment contract; applications open till April 17
India’s first prospective study finds molecular testing improved diagnostic clarity in 50% of complex sarcoma cases
The FDA classified LifeVac as a Class II medical device
Subscribe To Our Newsletter & Stay Updated